Original ArticleAddressing DRESS (drug reaction with eosinophilia and systemic symptoms)McGrath, Catherine M.a,b; Khangura, KaramjitcAuthor Information aSchool of Immunity and Infection, Rheumatology Research Group, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham bDepartment of Rheumatology cDepartment of Pharmacy, Sandwell and West Birmingham Hospitals NHS Trust, Lyndon, West Bromwich, West Midlands, UK Correspondence to Catherine M. McGrath, Department of Rheumatology, Russells Hall Hospital, Pensnett Road, Dudley, West Midlands UK. E-mail: [email protected] Editor: R E Ferner, MSc, MD, FRCP, Director of the West Midlands Centre for Adverse Drug Reaction Reporting and Consultant Physician at City Hospital, Birmingham, UK. Assistant Editor: Mr C Anton, MA, MEng. Editorial Board: Australia: Dr M Kennedy, Professor G M Shenfield, Denmark: Professor J S Schou; England: Dr J K Aronson; India: Professor N Gogtay; Netherlands: Professor C J van Boxtel, Dr B H Ch Stricker; New Zealand: Dr T Maling; Scotland: Dr D N Bateman; Wales: Professor P A Routledge. Adverse Drug Reaction Bulletin: December 2015 - Volume 295 - Issue 1 - p 1139-1142 doi: 10.1097/FAD.0000000000000013 Buy Metrics Abstract Summary The syndrome of drug reaction with eosinophilia and systemic symptoms (DRESS) is the manifestation of a severe idiosyncratic drug-induced reaction with variable latency period. DRESS occurs in one in 1000 to one in 10 000 of drug exposures with high rates of long-term sequelae and mortality of around 10%. There are several classes of drugs historically associated with DRESS – aromatic antiepileptics such as carbamazepine and related compounds, nonsteroidal anti-inflammatory drugs, antiretroviral drugs and antibiotics as well as drugs such as sulfasalazine, allopurinol and dapsone. There is growing recognition of the role of genetic predisposition. Implicated alleles can sometimes be used for predrug screening. DRESS can be associated with reactivation of human herpes viruses, which may be important in a prolonged and severe disease course. Prompt recognition of DRESS, withdrawal of the suspect drug under clinical supervision and supportive care are vital. Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.